Anthony Hickey

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Efficacy of inhaled CPZEN-45 in treating tuberculosis in the guinea pig

Inhaled antibodies: Quality and performance considerations

COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea

A SPLUNC1 peptidomimetic inhibits orai1 and reduces inflammation in a murine allergic asthma model

In vitro-in vivo correlation of pharmaceutical aerosols

A technology evaluation of CVT-301 (Inbrija): An inhalable therapy for treatment of Parkinson's disease

Preclinical evaluation of inhalational spectinamide-1599 therapy against Tuberculosis

Efficacy of combined Rifampicin formulations delivered by the pulmonary route to treat tuberculosis in the guinea pig model

Microfluidic and organ-on-a-chip approaches to investigate cellular and microenvironmental contributions to cardiovascular function and pathology

A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans

User-life of ICS/LABA inhaler devices should be considered when prescribed as relievers

Emerging trends in inhaled drug delivery

Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnostics via spray drying

Synergistic drug combinations and machine learning for drug repurposing in chordoma

A New Natural Defense Against Airborne Pathogens

Why we need to deliver large amounts of powder to the lungs and the concurrent challenges

Characterization of spray dried pyrazinoic acid for high dose aerosol delivery and analysis of efficiency between devices

Nanoparticle technology for respiratory tract mucosal vaccine delivery

Why wait?: The case for treating tuberculosis with inhaled drugs

A spray-dried combination of capreomycin and cpzen-45 for inhaled tuberculosis therapy